Jennifer McKie Adams, Director at Eton Pharmaceuticals, Inc. (ETON), sold 50,000 shares at $32.48 ($1.6M) on 2026-06-17, disclosed to the SEC on 2026-06-17.
Open-market sale of $1.6M ETON by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.